バイオテクノロジーにおけるAIの世界市場レポート 2025年

バイオテクノロジーにおけるAIの市場規模は、今後数年間で飛躍的な成長が見込まれます。2029年にはCAGR24.6％で134億米ドルに成長します。予測期間の成長は、AI技術の採用の増加、AIバイオベンチャー企業への投資の増加、毒物学研究におけるAIの利用の拡大、がん研究におけるAI主導の予測モデルの出現、AI主導の薬剤再利用分野の拡大に起因すると考えられます。この期間に予想される主な動向には、ディープラーニングとニューラルネットワークの発展、AIとゲノミクスおよびプロテオミクスの統合、AI主導型CRISPR遺伝子編集の進展、ファーマコビジランスにおけるAIの利用、AIベースのコンパニオン診断薬の開発などがあります。

人工知能（AI）の採用拡大がバイオテクノロジーにおけるAI市場の拡大を牽引すると予想されています。AIとは、機械、特にコンピュータシステムが人間の認知機能をシミュレーションし、学習、推論、問題解決などのタスクを実行することを指します。AIの導入が増加している背景には、特に複雑なデータ分析を高い精度で自動化することで、幅広い産業において効率性、精度、意思決定を改善する能力があることが挙げられます。バイオテクノロジーでは、AIが創薬を大幅に加速し、調査プロセスを合理化し、予測モデリングを強化することで、最終的にヘルスケア成果の向上に貢献します。例えば、2024年10月、英国の科学イノベーション技術省（DSIT）は、2023年のAI企業数が17％増加（543社増）、AIが生み出す収益が34％増加（36億英ポンド増）、雇用が29％増加（1万4,500人増）、粗付加価値額（GVA）が2022年比で57％近く増加（21億英ポンド増）など、AIの活動が顕著に増加すると報告しました。その結果、AIの採用拡大がAI主導型バイオテクノロジー市場の成長を後押ししています。

バイオテクノロジーにおけるAI分野の主要企業は、市場での地位を強化するために、抗体探索のためのAI搭載プラットフォームなどの先進技術の開発を優先しています。これらのプラットフォームは、AIを活用して治療抗体を効率的に同定・最適化し、コスト削減と臨床転帰の改善を実現しながら医薬品開発を加速します。例えば、イスラエルを拠点とするベンチャースタジオのAION Labsは2023年2月、治療用抗体のde novo探索に特化した革新的なプラットフォームDenovAIを発表しました。この最先端のシステムは、機械学習と計算生物物理学を統合し、親和性の高い抗体候補を同定することで、配列の多様性、精度の向上、開発サイクルの短縮を実現します。DenovAIは、バイオテクノロジーにおける大きな飛躍を意味し、より迅速で安価な創薬を促進し、様々な疾患領域における臨床成功の可能性を高めます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場-金利、インフレ、地政学、貿易戦争と関税、コロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のバイオテクノロジーにおけるAIのPESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のバイオテクノロジーにおけるAI市場：成長率分析
• 世界のバイオテクノロジーにおけるAI市場の実績：規模と成長、2019年～2024年
• 世界のバイオテクノロジーにおけるAI市場の予測：規模と成長、2024年～2029年、2034年
• 世界のバイオテクノロジーにおけるAI総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のバイオテクノロジーにおけるAI市場：コンポーネント別、実績と予測、2019年～2024年、2024年～2029年、2034年
• ソフトウェア
• ハードウェア
• サービス
• 世界のバイオテクノロジーにおけるAI市場：用途別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 医薬品の発見と開発
• 臨床試験・最適化
• 医療画像
• 診断
• その他の用途
• 世界のバイオテクノロジーにおけるAI市場：エンドユーザー別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 製薬会社
• バイオテクノロジー企業
• 学術研究機関
• ヘルスケア提供者
• 受託調査機関（CRO）・受託開発製造機関（CDMO）
• その他のエンドユーザー
• 世界のバイオテクノロジーにおけるAI市場：ソフトウェアのサブセグメンテーション、タイプ別、実績と予測、2019年～2024年、2024年～2029年、2034年
• AIを活用したデータ分析ツール
• 機械学習アルゴリズム
• バイオインフォマティクスソフトウェア
• 創薬プラットフォーム
• 臨床試験管理ソフトウェア
• 世界のバイオテクノロジーにおけるAI市場、ハードウェアのサブセグメンテーション、タイプ別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 高性能コンピューティング（HPC）システム
• AI統合型画像機器
• データストレージソリューション
• 実験室自動化機器
• ウェアラブル健康モニタリングデバイス
• 世界のバイオテクノロジーにおけるAI市場、サービスのサブセグメンテーション、タイプ別、実績と予測、2019年～2024年、2024年～2029年、2034年
• AI実装・統合サービス
• コンサルティング・トレーニングサービス
• クラウドベースのAIソリューション
• 保守・サポートサービス
• カスタムAIモデル開発

第7章 地域別・国別分析

• 世界のバイオテクノロジーにおけるAI市場：地域別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 世界のバイオテクノロジーにおけるAI市場：国別、実績と予測、2019年～2024年、2024年～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• バイオテクノロジーにおけるAI市場：競合情勢
• バイオテクノロジーにおけるAI市場：企業プロファイル
  • Google LLC Overview, Products and Services, Strategy and Financial Analysis
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • International Business Machines Corporation（IBM）Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Bayer AG
• Sanofi S.A.
• Bristol-Myers Squibb Company
• AstraZeneca Plc
• Abbott Laboratories
• Novartis AG
• Roivant Sciences Ltd.
• Gilead Sciences Inc.
• NVIDIA Corporation
• Amgen Inc.
• Novo Nordisk A/S
• Merck KGaA
• Biogen Inc.
• CareDx Inc.
• Clario Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• バイオテクノロジーにおけるAI市場、2029年：新たな機会を提供する国
• バイオテクノロジーにおけるAI市場、2029年：新たな機会を提供するセグメント
• バイオテクノロジーにおけるAI市場、2029年：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Artificial intelligence (AI) in biotechnology involves the application of machine learning and data-driven algorithms to interpret biological data and accelerate scientific research. It plays a vital role in areas such as drug discovery, genomics, diagnostics, and personalized medicine by recognizing patterns and forecasting outcomes. AI improves operational efficiency, reduces research costs, and provides deeper insights into complex biological systems, fueling innovation in healthcare and life sciences.

The primary components of AI in biotechnology include software, hardware, and services. Software in this context consists of sophisticated computational tools and algorithms that analyze biological data, simulate complex biological systems, and speed up processes such as drug development, genomic analysis, and precision medicine. It supports applications such as drug discovery and development, clinical trial optimization, medical imaging, diagnostics, and more, serving end users such as pharmaceutical and biotechnology companies, academic and research institutions, healthcare providers, contract research organizations (CROs), contract development and manufacturing organizations (CDMOs), and others.

The AI in biotechnology market research report is one of a series of new reports from The Business Research Company that provides AI in biotechnology market statistics, including AI in biotechnology industry global market size, regional shares, competitors with a AI in biotechnology market share, detailed AI in biotechnology market segments, market trends and opportunities, and any further data you may need to thrive in the AI in biotechnology industry. This AI in biotechnology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The AI in biotechnology market size has grown exponentially in recent years. It will grow from$4.46 billion in 2024 to $5.56 billion in 2025 at a compound annual growth rate (CAGR) of 24.8%. The growth during the historic period can be attributed to the rise in computational capabilities, the expansion of AI-driven drug discovery efforts, the increasing application of AI in microbiome research, the emergence of AI in regenerative medicine, and the growing adoption of AI in agricultural biotechnology.

The AI in biotechnology market size is expected to see exponential growth in the next few years. It will grow to$13.40 billion in 2029 at a compound annual growth rate (CAGR) of 24.6%. The growth in the forecast period can be attributed to the increasing adoption of AI technologies, rising investments in AI-biotech startups, growing use of AI in toxicology studies, the emergence of AI-driven predictive models in cancer research, and the expanding field of AI-driven drug repurposing. Key trends expected during this period include advancements in deep learning and neural networks, the integration of AI with genomics and proteomics, progress in AI-driven CRISPR gene editing, the use of AI in pharmacovigilance, and the development of AI-based companion diagnostics.

he growing adoption of artificial intelligence (AI) is anticipated to drive the expansion of the AI in biotechnology market. AI refers to the simulation of human cognitive functions by machines, particularly computer systems, to execute tasks such as learning, reasoning, and problem-solving. The rise in AI adoption is fueled by its ability to improve efficiency, precision, and decision-making across a wide range of industries, particularly through automating complex data analysis with high accuracy. In biotechnology, AI significantly accelerates drug discovery, streamlines research processes, and enhances predictive modeling, ultimately contributing to better healthcare outcomes. For example, in October 2024, the UK's Department for Science, Innovation & Technology (DSIT) reported a notable increase in AI activity in 2023, including a 17% rise in the number of AI companies (+543), a 34% boost in AI-generated revenue (+£3.6 billion), a 29% growth in employment (+14,500), and a nearly 57% increase in gross value added (GVA) (+£2.1 billion) compared to 2022. As a result, the expanding adoption of AI is propelling growth in the AI-driven biotechnology market.

Leading companies in the AI in biotechnology sector are prioritizing the development of advanced technologies, such as AI-powered platforms for antibody discovery, to strengthen their market position. These platforms leverage AI to efficiently identify and optimize therapeutic antibodies, accelerating drug development while reducing costs and improving clinical outcomes. For instance, in February 2023, AION Labs, a venture studio based in Israel, introduced DenovAI-an innovative platform dedicated to the de novo discovery of therapeutic antibodies. This state-of-the-art system integrates machine learning with computational biophysics to identify high-affinity antibody candidates, offering greater sequence diversity, enhanced precision, and shorter development cycles. DenovAI represents a significant leap in biotechnology, facilitating faster, more affordable drug discovery and increasing the likelihood of clinical success across various disease areas.

In February 2025, Incyte Corporation, a U.S.-based biopharmaceutical firm, entered into a strategic partnership with Genesis Therapeutics Inc. to harness the potential of AI in enhancing drug discovery efficiency. The partnership combines Incyte's deep expertise in drug development with Genesis Therapeutics' proprietary AI platform to accelerate the discovery and refinement of innovative small molecule therapies for targeted oncology treatments. Genesis Therapeutics Inc. is a U.S.-based biotechnology company that specializes in AI-powered drug discovery, aiming to revolutionize therapeutic development through advanced technological applications.

Major players in the ai in biotechnology market are Google LLC, Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., International Business Machines Corporation (IBM), Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca Plc, Abbott Laboratories, Novartis AG, Roivant Sciences Ltd., Gilead Sciences Inc., NVIDIA Corporation, Amgen Inc., Novo Nordisk A/S, Merck KGaA, Biogen Inc., CareDx Inc., Clario Inc., BenevolentAI Limited, Recursion Pharmaceuticals Inc., Insilico Medicine Inc., and Genesis Therapeutics Inc.

North America was the largest region in the AI in biotechnology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in AI in biotechnology report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the AI in biotechnology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The AI in biotechnology market consists of revenues earned by entities providing services such as genomics analysis, precision medicine development, biomanufacturing optimization, and AI-driven diagnostics. The market value includes the value of related goods sold by the service provider or included within the service offering. The AI in biotechnology market also includes sales of bioinformatics tools, automation systems, and AI-integrated laboratory equipment. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

AI In Biotechnology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on ai in biotechnology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for ai in biotechnology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The ai in biotechnology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Component: Software; Hardware; Services
• 2) By Application: Drug Discovery And Development; Clinical Trials And Optimization; Medical Imaging; Diagnostics; Other Applications
• 3) By End User: Pharmaceutical Companies; Biotechnology Companies; Academic And Research Institutes; Healthcare Providers; Contract Research Organization (CRO) And Contract Development And Manufacturing Organization (CDMO); Other End Users
• Subsegments:
• 1) By Software: AI-Powered Data Analytics Tools: Machine Learning Algorithms; Bioinformatics Software; Drug Discovery Platforms; Clinical Trial Management Software
• 2) By Hardware: High-Performance Computing (HPC) Systems; AI-Integrated Imaging Devices: Data Storage Solutions; Laboratory Automation Equipment; Wearable Health Monitoring Devices
• 3) By Services: AI Implementation And Integration Services; Consulting And Training Services; Cloud-Based AI Solutions; Maintenance And Support Services; Custom AI Model Development
• Companies Mentioned: Google LLC; Pfizer Inc.; Johnson & Johnson Services Inc.; F. Hoffmann-La Roche Ltd.; International Business Machines Corporation (IBM)
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. AI In Biotechnology Market Characteristics

3. AI In Biotechnology Market Trends And Strategies

4. AI In Biotechnology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global AI In Biotechnology Growth Analysis And Strategic Analysis Framework

• 5.1. Global AI In Biotechnology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global AI In Biotechnology Market Growth Rate Analysis
• 5.4. Global AI In Biotechnology Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global AI In Biotechnology Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global AI In Biotechnology Total Addressable Market (TAM)

6. AI In Biotechnology Market Segmentation

• 6.1. Global AI In Biotechnology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Software
• Hardware
• Services
• 6.2. Global AI In Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drug Discovery And Development
• Clinical Trials And Optimization
• Medical Imaging
• Diagnostics
• Other Applications
• 6.3. Global AI In Biotechnology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical Companies
• Biotechnology Companies
• Academic And Research Institutes
• Healthcare Providers
• Contract Research Organization (CRO) And Contract Development And Manufacturing Organization (CDMO)
• Other End Users
• 6.4. Global AI In Biotechnology Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• AI-Powered Data Analytics Tools
• Machine Learning Algorithms
• Bioinformatics Software
• Drug Discovery Platforms
• Clinical Trial Management Software
• 6.5. Global AI In Biotechnology Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• High-Performance Computing (HPC) Systems
• AI-Integrated Imaging Devices
• Data Storage Solutions
• Laboratory Automation Equipment
• Wearable Health Monitoring Devices
• 6.6. Global AI In Biotechnology Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• AI Implementation and Integration Services
• Consulting and Training Services
• Cloud-Based AI Solutions
• Maintenance and Support Services
• Custom AI Model Development

7. AI In Biotechnology Market Regional And Country Analysis

• 7.1. Global AI In Biotechnology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global AI In Biotechnology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific AI In Biotechnology Market

• 8.1. Asia-Pacific AI In Biotechnology Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific AI In Biotechnology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific AI In Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific AI In Biotechnology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China AI In Biotechnology Market

• 9.1. China AI In Biotechnology Market Overview
• 9.2. China AI In Biotechnology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China AI In Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China AI In Biotechnology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India AI In Biotechnology Market

• 10.1. India AI In Biotechnology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India AI In Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India AI In Biotechnology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan AI In Biotechnology Market

• 11.1. Japan AI In Biotechnology Market Overview
• 11.2. Japan AI In Biotechnology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan AI In Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan AI In Biotechnology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia AI In Biotechnology Market

• 12.1. Australia AI In Biotechnology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia AI In Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia AI In Biotechnology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia AI In Biotechnology Market

• 13.1. Indonesia AI In Biotechnology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia AI In Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia AI In Biotechnology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea AI In Biotechnology Market

• 14.1. South Korea AI In Biotechnology Market Overview
• 14.2. South Korea AI In Biotechnology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea AI In Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea AI In Biotechnology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe AI In Biotechnology Market

• 15.1. Western Europe AI In Biotechnology Market Overview
• 15.2. Western Europe AI In Biotechnology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe AI In Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe AI In Biotechnology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK AI In Biotechnology Market

• 16.1. UK AI In Biotechnology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK AI In Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK AI In Biotechnology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany AI In Biotechnology Market

• 17.1. Germany AI In Biotechnology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany AI In Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany AI In Biotechnology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France AI In Biotechnology Market

• 18.1. France AI In Biotechnology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France AI In Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France AI In Biotechnology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy AI In Biotechnology Market

• 19.1. Italy AI In Biotechnology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy AI In Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy AI In Biotechnology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain AI In Biotechnology Market

• 20.1. Spain AI In Biotechnology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain AI In Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain AI In Biotechnology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe AI In Biotechnology Market

• 21.1. Eastern Europe AI In Biotechnology Market Overview
• 21.2. Eastern Europe AI In Biotechnology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe AI In Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe AI In Biotechnology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia AI In Biotechnology Market

• 22.1. Russia AI In Biotechnology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia AI In Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia AI In Biotechnology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America AI In Biotechnology Market

• 23.1. North America AI In Biotechnology Market Overview
• 23.2. North America AI In Biotechnology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America AI In Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America AI In Biotechnology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA AI In Biotechnology Market

• 24.1. USA AI In Biotechnology Market Overview
• 24.2. USA AI In Biotechnology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA AI In Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA AI In Biotechnology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada AI In Biotechnology Market

• 25.1. Canada AI In Biotechnology Market Overview
• 25.2. Canada AI In Biotechnology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada AI In Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada AI In Biotechnology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America AI In Biotechnology Market

• 26.1. South America AI In Biotechnology Market Overview
• 26.2. South America AI In Biotechnology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America AI In Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America AI In Biotechnology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil AI In Biotechnology Market

• 27.1. Brazil AI In Biotechnology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil AI In Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil AI In Biotechnology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East AI In Biotechnology Market

• 28.1. Middle East AI In Biotechnology Market Overview
• 28.2. Middle East AI In Biotechnology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East AI In Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East AI In Biotechnology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa AI In Biotechnology Market

• 29.1. Africa AI In Biotechnology Market Overview
• 29.2. Africa AI In Biotechnology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa AI In Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa AI In Biotechnology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. AI In Biotechnology Market Competitive Landscape And Company Profiles

• 30.1. AI In Biotechnology Market Competitive Landscape
• 30.2. AI In Biotechnology Market Company Profiles
  • 30.2.1. Google LLC Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. International Business Machines Corporation (IBM) Overview, Products and Services, Strategy and Financial Analysis

31. AI In Biotechnology Market Other Major And Innovative Companies

• 31.1. Bayer AG
• 31.2. Sanofi S.A.
• 31.3. Bristol-Myers Squibb Company
• 31.4. AstraZeneca Plc
• 31.5. Abbott Laboratories
• 31.6. Novartis AG
• 31.7. Roivant Sciences Ltd.
• 31.8. Gilead Sciences Inc.
• 31.9. NVIDIA Corporation
• 31.10. Amgen Inc.
• 31.11. Novo Nordisk A/S
• 31.12. Merck KGaA
• 31.13. Biogen Inc.
• 31.14. CareDx Inc.
• 31.15. Clario Inc.

32. Global AI In Biotechnology Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The AI In Biotechnology Market

34. Recent Developments In The AI In Biotechnology Market

35. AI In Biotechnology Market High Potential Countries, Segments and Strategies

• 35.1 AI In Biotechnology Market In 2029 - Countries Offering Most New Opportunities
• 35.2 AI In Biotechnology Market In 2029 - Segments Offering Most New Opportunities
• 35.3 AI In Biotechnology Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer